| Target Price consensus revisions : last 18 months |
|
|
|
| Evolution of the average Target Price on BIOCRYST PHARMACEUTICALS, |
|
|
|
Data source :
© 2017 Thomson Reuters |
|
|
|
| Mean consensus |
OUTPERFORM |
| Number of Analysts |
10 |
| Average target price |
9,11 $ |
| Last Close Price |
5,24 $ |
| Spread / Highest target |
186% |
| Spread / Average Target |
74% |
| Spread / Lowest Target |
-24% |
Consensus revision (last 18 months)
|
United Kingdom
France
Deutschland
Schweiz (DE)
